HMOX1 and Alzheimer disease: In addition, the inhibition of HO-1 by azole-based, a brain-permeable inhibitor of HO-1, OB-28, led to the significant improvement in a complex maze learning task relative to saline-treated controls, indicating the amelioration of behavioral anomalies in the transgenic mouse model of AD through HO-1 down-regulation [156].